BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 123 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $128,000 | -33.3% | 16,800 | -51.4% | 0.03% | +21.4% |
| Q2 2017 | $192,000 | +74.5% | 34,600 | +98.9% | 0.03% | +64.7% |
| Q4 2016 | $110,000 | -37.1% | 17,400 | +48.5% | 0.02% | -60.5% |
| Q2 2015 | $175,000 | -21.5% | 11,719 | -36.0% | 0.04% | -41.9% |
| Q4 2014 | $223,000 | -35.2% | 18,300 | -43.7% | 0.07% | -26.7% |
| Q1 2014 | $344,000 | – | 32,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |